Literature DB >> 20140769

Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia).

Partha Pratim Chakraborty1, Sagnik Mukhopadhyay, Arun Achar, Mallika Pal, Prabodh Chandra Mondal.   

Abstract

Metabolic disorders are often encountered in clinical practice. Some of these diseases are associated with dermatological and musculoskeletal manifestations. Familial hypercholesterolemia is a disorder of lipoprotein metabolism characterized by elevated cholesterol, low-density lipoprotein cholesterol, xanthomas and early onset atherosclerosis. Tendinitis and arthritis have been rarely reported in patients with familial hypercholesterolemia. Here is presented a case of a young girl with migratory polyarthritis, who was diagnosed as probable homozygote familial hypercholesterolemia with hypercholesterolemic arthritis. A proper knowledge of cutaneous manifestations helps to identify patients at risk, establish the underlying diagnosis, and start early and effective therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20140769     DOI: 10.1007/s12098-010-0021-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  5 in total

1.  Hypercholesterolemic (type II hyperlipoproteinemic) arthritis.

Authors:  D Rimon; L Cohen
Journal:  J Rheumatol       Date:  1989-05       Impact factor: 4.666

2.  [Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy].

Authors:  Rodrigo Alonso; Jaime Fernández de Bobadilla; Ignacio Méndez; Pablo Lázaro; Nelva Mata; Pedro Mata
Journal:  Rev Esp Cardiol       Date:  2008-04       Impact factor: 4.753

Review 3.  Familial hypercholesterolemia: current treatment and advances in management.

Authors:  Roeland Huijgen; Maud N Vissers; Joep C Defesche; Peter J Lansberg; John J P Kastelein; Barbara A Hutten
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-04

4.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel L Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico P Veltri; A David Marais; Eric de Groot
Journal:  N Engl J Med       Date:  2008-03-30       Impact factor: 91.245

5.  Musculoskeletal manifestations in hyperlipidaemia: a controlled study.

Authors:  P Klemp; A M Halland; F L Majoos; K Steyn
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.